TOP STORIES

• REGULATORY Tokyo Prosecutors Raid Novartis Japan Office over Diovan Ads
  February 20, 2014

• REGULATORY Penalty for Lengthy Drug Price Haggling – Interview 1: “It Can’t Be Helped” Says Idaikyo Exec Koyama
  February 19, 2014

• ACADEMIA Japan Hypertension Society Halts Support for Maker-Linked Seminars, but Gives Leeway for Luncheons
  February 18, 2014

• BUSINESS Blopress AGs Approved, Yet Blurry Prospect for Their June Listing
  February 17, 2014

• REGULATORY 34 Firms Win Approval for Diovan Generics, 31 for Preminent Generics towards June Listing
  February 17, 2014

• BUSINESS Nichi-Iko on Tap to Enter US Market, Remicade Biosimilar Debut Eyed around 2018
  February 14, 2014

• ACADEMIA University of Tokyo Hospital Allegedly Gave Patient Questionnaire Results on SIGN Trial to Novartis without Consent
  February 13, 2014

• REGULATORY Chuikyo Submits Recommendations for FY2014 Revision; Hospitals, Pharmacies with Low Settlement Rates to Face Fee Cuts of Up to 26％
  February 12, 2014

• ORGANIZATION Prof. Tsuchiya Slams Kowa’s Livalo Trademark Suit
  February 10, 2014

• ACADEMIA University of Tokyo Besieged with Medical, Pharma Research Woes, School’s Credibility at Stake
  February 7, 2014

• BUSINESS Kyorin Pushes Easy to Use Inhaler Flutiform, Aims for Higher Market Penetration
  February 6, 2014

• REGULATORY PMDA’s Next 5-Year Plan to Embrace New Generic Unit, Benchmarks for Review Time
  February 5, 2014

• BUSINESS Drug Wholesalers Laud Medical Fee Cuts to Fix Lengthy Haggling, Pharmacy Chains Vexed by Rule
  February 4, 2014

• BUSINESS Teijin Picks Another Pharma Maven for President
  February 3, 2014

• BUSINESS Sanofi Demands Payment of $416 Million from Novartis over Dissolved Equa Deal
  January 31, 2014

• BUSINESS Novartis Suspected of Drafting Letter of Consent for “Sign” Trial
  January 30, 2014

• BUSINESS Shionogi Influenza Campaign Causes Stir among Healthcare Professionals
  January 29, 2014

• ACADEMIA JCS’s 2013 Guidelines for Treatment of AF Recommend Dabigatran and Apixaban in Moderate-Risk Patients
  January 29, 2014

• REGULATORY MHLW Setting Out on Development of iPS Tech-Based Cardiotoxicity Evaluation
  January 28, 2014

• BUSINESS Ajinomoto to Downsize In-House Drug Discovery Research amid Slack Pharma Biz
  January 27, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 204
• 205
• 206
• 207
• 208
• 209
• 210
• 211
• 212
• …
• Next ›
• 最終 »